Physician profile
Kurian C Thott
NPI 1508074857
$216,089.15
in general payments reported to CMS, 2019-2025
38 companies · $80K in 2025
The $80K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,813 · 2020: $4,739 · 2021: $20K · 2022: $25K · 2023: $41K · 2024: $38K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $117K · Travel and Lodging: $22K · Education: $13K · Food and Beverage: $4,293 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Entertainment: $22.64 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $117,409.95 |
| Travel and Lodging | $21,868.55 |
| Education | $12,692.00 |
| Food and Beverage | $4,293.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Entertainment | $22.64 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $107,337.42 | 2019-2025 | Enseal X1, Harmonic, Enseal |
| Ethicon US, LLC | $52,645.64 | 2020-2025 | Harmonic, Enseal, Ethicon |
| Intuitive Surgical, INC. | $22,163.75 | 2023-2025 | Da Vinci Surgical System, Davinci Xi |
| Ethicon Endo-Surgery INC. | $17,550.00 | 2024-2025 | Enseal, Harmonic |
| Ethicon INC. | $9,137.50 | 2020-2022 | |
| Mimedx Group, INC. | $4,097.50 | 2025 | |
| Momentis Surgical INC. | $851.00 | 2022 | |
| Abbvie INC. | $332.93 | 2019-2025 | |
| Caldera Medical, INC | $254.54 | 2021-2023 | Desara |
| Sumitomo Pharma America, INC. | $227.13 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $183.66 | 2019-2024 | |
| Axonics, INC. | $178.29 | 2022-2023 | Axonics |
| Boston Scientific Corporation | $140.00 | 2022-2025 | Upsylon, Advantage System, Axonics |
| Merck Sharp & Dohme LLC | $117.04 | 2019-2025 | Bridion |
| Organon LLC | $94.12 | 2022-2025 | Nexplanon, Nuvaring |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurian Thott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.